Fabry's Disease Clinical Trial
Official title:
A Study to Investigate Safety and Tolerability of Higher Infusion Rate to shORten the duraTion of FabrazymE Infusion
This Phase 4 study will evaluate the safety and tolerability of Fabrazyme at current approved dose with increases in the infusion rate and reduced infusion volume. This study aims to generate data to provide the guidance on how infusion rate can be safely increased and minimize the burden of the life-long treatment with Fabrazyme.
The total duration will be up to 6 months ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01178164 -
Prevalence of Fabry's Disease in a Population of Patients With Chronic Pains
|
N/A | |
Terminated |
NCT02582294 -
Fabry's Disease and Pregnancy (PREFAB)
|
||
Recruiting |
NCT02469181 -
Impact of Enzyme Replacement Therapy on Cardiac Function in Patients With Fabry's Cardiomyopathy (RECAFTURE Trial)
|
||
Completed |
NCT02798458 -
Evaluation of the Gastrointestinal Manifestation of Fabry's Disease
|
N/A | |
Completed |
NCT00001491 -
Analysis of the Nervous System in Patients With Fabry's Disease
|
N/A | |
Completed |
NCT02450604 -
Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain
|
N/A | |
Recruiting |
NCT04847713 -
Early Detection and Follow-Up of Patients With Fabry's Disease
|